Logo - International Journal of Pharmaceutical Compounding

Case Report: Pediatric Scar Management After Open-heart Surgery

Author(s):  Phan Ha, Harger Beau, Estrada Nick

Issue:  Jul/Aug 2016 - Volume 20, Number 4
View All Articles in Issue

Abstract:  Tetralogy of Fallot is a congenital disease caused by structural defects within the heart that can lead to cyanosis. The purpose of this case report is to discuss the use of PracaSil-Plus, a proprietary topical anhydrous silicone base containing pracaxi oil, in scar-management therapy, following open-heart surgery on a pediatric patient with tetralogy of Fallot. The Patient and Observer Scar Assessment Scale was the research instrument used to evaluate for efficacy of the scar therapy. Following 8 weeks of treatment with PracaSil-Plus, reduction in scores were observed for scar color, stiffness, thickness, and irregularity, with improvements of 87.5%, 90.0%, 66.7%, and 66.7% from baseline, respectively. The post-treatment scar was similar to normal skin in appearance, with a 77.8% improvement in the total score. These results show that PracaSil-Plus may be a valuable option for practitioners and pharmacists to consider in pediatric scar-management therapy.

Related Keywords: Ha Phan, PharmD, RPh, Beau Harger, PharmD, RPh, Nick Estrada, PharmD, RPh, tetralogy of Fallot, congenital heart disease, cardiac abnormality, neonate, infant, scar tissue, surgical repair, PracaSil-Plus, wound healing, case report, pracaxi oil, topical preparations, anhydrous silicone base, cyanosis, blue baby syndrome, Patient and Observer Scar Assessment Scale, POSAS, quality of life


Purchase this article for download in electronic PDF format from IJPC at for $35 at:

Search the entire IJPC archive by keyword, topic, or issue at: